Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Accelerate Diagnostics (GB:0H8E)
LSE:0H8E
RESEARCH TOOLSreports
Accelerate Diagnostics (0H8E) Share Price & Analysis
0 Followers
0H8E Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.85 - $9.19
Previous Close$0.85
Volume0.00
Average Volume (3M)1.01K
Market Cap
$15.96M
Enterprise Value$41.96M
Total Cash (Recent Filing)$13.22M
Total Debt (Recent Filing)$39.22M
Price to Earnings (P/E)-0.2
Beta0.32
Next Earnings
May 09, 2024EPS Estimate
-$0.55Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.51
Shares Outstanding21,664,387
10 Day Avg. Volume58
30 Day Avg. Volume1,008
Standard Deviation0.23
R-Squared0.04
Alpha-0.00308
Financial Highlights & Ratios
Price to Book (P/B)-0.89
Price to Sales (P/S)16.29
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.48
Enterprise Value/Gross Profit16.45
Enterprise Value/Ebitda-0.73
Forecast
1Y Price Target
$1.00Price Target Upside17.51% Upside
Rating ConsensusHold
Number of Analyst Covering1
Accelerate Diagnostics News
Options Prices
Currently, No data available
---
Ownership Overview
40.59% Insiders
1.72% Mutual Funds
7.83% Other Institutional Investors
49.86% Public Companies and
Individual Investors
0H8E FAQ
What was Accelerate Diagnostics’s price range in the past 12 months?
Accelerate Diagnostics lowest share price was $0.85 and its highest was $9.19 in the past 12 months.
What is Accelerate Diagnostics’s market cap?
Currently, no data Available
When is Accelerate Diagnostics’s upcoming earnings report date?
Accelerate Diagnostics’s upcoming earnings report date is May 09, 2024 which is in 21 days.
How were Accelerate Diagnostics’s earnings last quarter?
Accelerate Diagnostics released its earnings results on Mar 28, 2024. The company reported -$0.789 earnings per share for the quarter, missing the consensus estimate of -$0.749 by -$0.04.
Is Accelerate Diagnostics overvalued?
According to Wall Street analysts Accelerate Diagnostics’s price is currently Undervalued.
Does Accelerate Diagnostics pay dividends?
Accelerate Diagnostics does not currently pay dividends.
What is Accelerate Diagnostics’s EPS estimate?
Accelerate Diagnostics’s EPS estimate is -$0.55.
How many shares outstanding does Accelerate Diagnostics have?
Accelerate Diagnostics has 21,664,387 shares outstanding.
What happened to Accelerate Diagnostics’s price movement after its last earnings report?
Accelerate Diagnostics reported an EPS of -$0.789 in its last earnings report, missing expectations of -$0.749. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Accelerate Diagnostics?
Among the largest hedge funds holding Accelerate Diagnostics’s share is Oracle Investment Management Inc. It holds Accelerate Diagnostics’s shares valued at 437K.
---
Accelerate Diagnostics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-90.18%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-51.76%
Trailing 12-Months
Company Description
Accelerate Diagnostics
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. Its products include Accelerate Pheno and Accelerate PhenoTest. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.
---
0H8E Earnings Call
Q4 2024
0:00 / 0:00
---
0H8E Stock 12 Months Forecast
Average Price Target
$1.00
▲(17.51% Upside)
Technical Analysis
Accelerate Diagnostics
―
Align Tech
―
Becton Dickinson
―
Anika Therapeutics
―
Hologic
―
---